Innovent Biologics, Inc. (IVBXF)
USD 6.88
(25.23%)
USD 6.88
(25.23%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 4.39 Billion CNY | 39.84% |
| 2022 | 3.62 Billion CNY | -1.93% |
| 2021 | 3.69 Billion CNY | 6.96% |
| 2020 | 3.45 Billion CNY | 274.58% |
| 2019 | 922.64 Million CNY | 9635.64% |
| 2018 | 9.47 Million CNY | -48.88% |
| 2017 | 18.53 Million CNY | -35.56% |
| 2016 | 28.76 Million CNY | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 454.32 Million USD | 0.0% |
| 2023 Q1 | 139.77 Million USD | -47.61% |
| 2023 FY | 5.06 Billion CNY | 39.84% |
| 2023 Q4 | 397.36 Million USD | 134.02% |
| 2023 Q3 | 169.8 Million USD | -46.43% |
| 2023 Q2 | 316.96 Million USD | 126.77% |
| 2022 Q2 | 271.99 Million USD | 0.0% |
| 2022 FY | 3.62 Billion CNY | -1.93% |
| 2022 Q4 | 266.77 Million USD | 130.99% |
| 2022 Q3 | 115.49 Million USD | -57.54% |
| 2021 FY | 3.69 Billion CNY | 6.96% |
| 2021 Q4 | 308.8 Million USD | 0.0% |
| 2021 Q2 | 263.75 Million USD | 0.0% |
| 2020 FY | 3.45 Billion CNY | 274.58% |
| 2020 Q4 | 392.05 Million USD | 0.0% |
| 2020 Q2 | 113.8 Million USD | 0.0% |
| 2019 Q4 | 85.2 Million USD | 0.0% |
| 2019 FY | 922.64 Million CNY | 9635.64% |
| 2019 Q2 | 42.77 Million USD | 0.0% |
| 2018 FY | 9.47 Million CNY | -48.88% |
| 2017 FY | 18.53 Million CNY | -35.56% |
| 2016 FY | 28.76 Million CNY | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Nuo Therapeutics, Inc. | 482.43 Thousand USD | -911783.308% |
| CNBX Pharmaceuticals Inc. | 410.16 Thousand USD | -1072450.315% |
| Mosaic ImmunoEngineering Inc. | - USD | -Infinity% |
| Evofem Biosciences, Inc. | 11.7 Million USD | -37480.95% |
| GB Sciences, Inc. | -624.00 USD | 705004266.667% |
| Inhibitor Therapeutics, Inc. | - USD | -Infinity% |
| NanoSphere Health Sciences Inc. | - USD | -Infinity% |
| Skye Bioscience, Inc. | -124.25 Thousand USD | 3540696.052% |
| Zenith Capital Corp. | - USD | -Infinity% |
| Agentix Corp. | - USD | -Infinity% |
| Arch Therapeutics, Inc. | -2439.00 USD | 180370169.701% |
| Biomind Labs Inc. | -15.42 Thousand USD | 28522052.801% |
| ContraFect Corporation | -154 Thousand USD | 2856740.26% |
| CSL Limited | 7.56 Billion USD | 41.817% |
| CytoDyn Inc. | -29 Thousand USD | 15169844.828% |
| GlobeStar Therapeutics Corporation | - USD | -Infinity% |
| Neon Bloom, Inc. | - USD | -Infinity% |
| Northwest Biotherapeutics, Inc. | -25.79 Million USD | 17152.585% |
| ProtoKinetix, Incorporated | -48.25 Thousand USD | 9115966.471% |
| Propanc Biopharma, Inc. | -34.15 Thousand USD | 12882167.35% |
| Regen BioPharma, Inc. | 176.56 Thousand USD | -2491532.306% |
| Santhera Pharmaceuticals Holding AG | 119.1 Million USD | -3593.49% |
| SQZ Biotechnologies Company | 9.79 Million USD | -44817.562% |
| Therapeutic Solutions International, Inc. | 62.22 Thousand USD | -7069655.408% |
| Eiger BioPharmaceuticals, Inc. | 14.99 Million USD | -29230.129% |
| Intellipharmaceutics International Inc. | 65.72 Thousand USD | -6692977.532% |
| Mesoblast Limited | -35.16 Million USD | 12609.173% |
| Marizyme, Inc. | 457.7 Thousand USD | -961055.075% |
| Genus plc | 178.7 Million USD | -2361.794% |
| Pharming Group N.V. | 220.1 Million USD | -1898.703% |
| Nymox Pharmaceutical Corporation | -11 Thousand USD | 39993063.636% |
| RegeneRx Biopharmaceuticals, Inc. | 76.76 Thousand USD | -5730969.163% |
| IMV Inc. | -962.29 Thousand USD | 457258.385% |
| AXIM Biotechnologies, Inc. | -387.5 Thousand USD | 1135381.199% |
| MultiCell Technologies, Inc. | 49.32 USD | -8919760646.148% |
| ONE Bio Corp. | 20.12 Million USD | -21759.029% |
| RVL Pharmaceuticals plc | 40.26 Million USD | -10825.682% |
| Arno Therapeutics, Inc. | - USD | -Infinity% |
| Emmaus Life Sciences, Inc. | 28.25 Million USD | -15469.726% |
| Provectus Biopharmaceuticals, Inc. | -1.14 Million USD | 385465.619% |
| Oncotelic Therapeutics, Inc. | 70 Thousand USD | -6284508.571% |
| THC Farmaceuticals, Inc. | -4952.00 USD | 88837458.643% |
| Acro Biomedical Co., Ltd. | 140.5 Thousand USD | -3131021.708% |
| Alpha Cognition Inc. | -86.02 Thousand USD | 5113814.14% |
| Enzolytics Inc. | 30.7 Thousand USD | -14325893.227% |
| MetaStat, Inc. | - USD | -Infinity% |
| argenx SE | 1.1 Billion USD | -296.87% |
| Enzon Pharmaceuticals, Inc. | - USD | -Infinity% |
| Endonovo Therapeutics, Inc. | -514.51 Thousand USD | 855132.167% |
| Genscript Biotech Corporation | 409.55 Million USD | -974.153% |
| Nanobac Pharmaceuticals, Incorporated | 3102.00 USD | -141818919.987% |
| Institute of Biomedical Research Corp. | - USD | -Infinity% |
| Sigyn Therapeutics, Inc. | -8856.00 USD | 49675190.334% |
| WPD Pharmaceuticals Inc. | - USD | -Infinity% |
| Cotinga Pharmaceuticals Inc. | -83.84 Thousand USD | 5246705.207% |
| VioQuest Pharmaceuticals, Inc. | - USD | -Infinity% |
| PsyBio Therapeutics Corp. | -50 Thousand USD | 8798552.0% |
| Adynxx, Inc. | - USD | -Infinity% |
| Sienna Biopharmaceuticals, Inc. | - USD | -Infinity% |
| Accustem Sciences Inc. | - USD | -Infinity% |
| Helix BioMedix, Inc. | 987.98 Thousand USD | -445174.352% |
| EV Biologics, Inc. | 48.9 Thousand USD | -8996272.188% |
| Q BioMed Inc. | -8988.00 USD | 48945649.622% |
| Capstone Therapeutics Corp. | 9.61 Million USD | -45672.823% |
| American Oriental Bioengineering, Inc. | 44.35 Million USD | -9817.59% |
| TetraLogic Pharmaceuticals Corporation | - USD | -Infinity% |
| BioStem Technologies, Inc. | 15.42 Million USD | -28420.387% |
| Curative Biotechnology, Inc. | -97.51 Thousand USD | 4511432.615% |
| HST Global, Inc. | - USD | -Infinity% |
| Burzynski Research Institute, Inc. | - USD | -Infinity% |
| Wesana Health Holdings Inc. | - USD | -Infinity% |
| Halberd Corporation | -208.00 USD | 2115012600.0% |
| Resverlogix Corp. | - USD | -Infinity% |
| Cell Source, Inc. | - USD | -Infinity% |
| RespireRx Pharmaceuticals Inc. | - USD | -Infinity% |
| GeneThera, Inc. | - USD | -Infinity% |
| AVAX Technologies, Inc. | 617.38 Thousand USD | -712459.12% |
| Ember Therapeutics, Inc. | - USD | -Infinity% |
| Anthera Pharmaceuticals, Inc. | - USD | -Infinity% |
| NovAccess Global Inc. | - USD | -Infinity% |
| Kadimastem Ltd | -630.13 Thousand USD | 698236.916% |
| VitaSpring Biomedical Co. Ltd. | - USD | -Infinity% |
| Rasna Therapeutics, Inc. | - USD | -Infinity% |
| Oncology Pharma Inc. | - USD | -Infinity% |
| Reve Technologies, Inc. | - USD | -Infinity% |
| LadRx Corporation | -11.83 Thousand USD | 37171422.349% |
| Regen BioPharma, Inc. | 176.56 Thousand USD | -2491532.306% |
| Affymax, Inc. | 1.35 Million USD | -324053.461% |
| Itoco Inc. | - USD | -Infinity% |
| Pathfinder Cell Therapy, Inc. | - USD | -Infinity% |
| Mobile Lads Corp. | - USD | -Infinity% |
| International Stem Cell Corporation | 4.6 Million USD | -95369.314% |
| Claritas Pharmaceuticals, Inc. | - USD | -Infinity% |
| Bioxytran, Inc. | -8285.00 USD | 53098784.369% |
| NDT Pharmaceuticals Inc. | - USD | -Infinity% |
| Qrons Inc. | - USD | -Infinity% |
| Alseres Pharmaceuticals, Inc. | 450.04 Thousand USD | -977412.371% |
| SYBLEU INC | 11.69 Thousand USD | -37612981.395% |
| Advanced Proteome Therapeutics Corporation | - USD | -Infinity% |
| Nascent Biotech, Inc. | -319.5 Thousand USD | 1376979.38% |
| Rebus Holdings, Inc. | - USD | -Infinity% |
| ImmunoCellular Therapeutics, Ltd. | - USD | -Infinity% |
| GlobeImmune, Inc. | - USD | -Infinity% |
| Predictive Technology Group, Inc. | - USD | -Infinity% |
| ProText Mobility, Inc. | - USD | -Infinity% |
| Cardax, Inc. | - USD | -Infinity% |
| VG Life Sciences Inc. | - USD | -Infinity% |
| Kaleido Biosciences, Inc. | - USD | -Infinity% |
| Advaxis, Inc. | - USD | -Infinity% |
| Adhera Therapeutics, Inc. | - USD | -Infinity% |
| RenovaCare, Inc. | - USD | -Infinity% |
| Regnum Corp. | - USD | -Infinity% |
| Innovation Pharmaceuticals Inc. | -373 Thousand USD | 1179517.158% |
| Neutra Corp. | 14.33 Thousand USD | -30688605.964% |
| Windtree Therapeutics, Inc. | -82 Thousand USD | 5365009.756% |
| PureTech Health plc | -1.6 Million USD | 274537.056% |
| Coeptis Therapeutics, Inc. | -1 Million USD | 439479.527% |
| IXICO plc | 3.27 Million USD | -134432.905% |
| IntelGenx Technologies Corp. | -694 Thousand USD | 633994.236% |
| Gelesis Holdings, Inc. | -1.79 Million USD | 245729.592% |
| CSL Limited | 7.7 Billion USD | 42.904% |
| Cellectis S.A. | 18 Thousand USD | -24440044.444% |